The impact of focused federal initiatives on pediatric cancer research
For the paper, The impact of focused federal initiatives on pediatric cancer research by Subhashini Jagu (first author), Gregory Reaman (senior author) et al in the journal Cancer, a summary and our perspective is:
Recommendation 1: Invest more in precision and targeted therapies
Continue expanding genomic research and data systems (like CCDI and STAR) to develop treatments tailored to specific cancer types and mutations, improving effectiveness while reducing harmful side effects.
Recommendation 2: Strengthen data sharing and collaboration globally
Build more connected data platforms and encourage collaboration between hospitals, researchers, and countries so rare pediatric cancers can be studied more effectively and quickly.
Recommendation 3: Sustain and expand funding for key programs
Maintain and grow support for initiatives like the STAR Act and CCDI to continue progress in research, biobanking, and cancer registries.
Here is our perspective:
Recommendation 1: Currently, investment in precision and targeted therapies for oncology overall is rising quickly, due to promising clinical outcomes, growing biotech sponsorship, and advancements in genomics. The precision oncology market is actually projected to reach over $230 billion by 2031. Genomic research and data systems are expanding rapidly around the world, because of factors like decreasing sequencing costs, the need for diverse datasets, and the integration of artificial intelligence (AI). Over 96 major genomics programs have been launched worldwide to integrate genomics into clinical care, with over 60 million people projected to have their genomes sequenced by 2025.
Recommendation 2: There are connected platforms and data-sharing networks being implemented between hospitals, research institutions, and technology partners to accelerate cancer research. One such platform is the Cancer AI Alliance (CAIA), founded in 2024, an alliance of top cancer centers across the U.S. They launched a scalable, multi-cloud federated learning platform, which allows institutions to train AI models on diverse patient data. We should also note that data sharing began with harmonizing the database terms between the US and Europe, pioneered by the University of Chicago “Data for the Common Good” team … years before CCDI. The Pediatric Cancer Data Commons remains a valuable tool.
Recommendation 3: The support for initiatives like the STAR Act and CCDI is growing, with the U.S. Department of Health and Human Services (HHS) announcing plans to double CCDI funding from $50 million to $100 million with plans to accelerate AI-backed research.
